440 related articles for article (PubMed ID: 14632658)
1. MHC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T lymphocytes directed by T-cell receptor type.
Sköld M; Stenström M; Sidobre S; Höglund P; Kronenberg M; Cardell S
Immunology; 2003 Nov; 110(3):313-21. PubMed ID: 14632658
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of Ly49 expression on CD4+ and CD4-CD8- (double negative) NK1.1+ T cells.
Sköld M; Cardell S
Eur J Immunol; 2000 Sep; 30(9):2488-96. PubMed ID: 11009081
[TBL] [Abstract][Full Text] [Related]
3. Regulation of NKT cells by Ly49: analysis of primary NKT cells and generation of NKT cell line.
Maeda M; Lohwasser S; Yamamura T; Takei F
J Immunol; 2001 Oct; 167(8):4180-6. PubMed ID: 11591738
[TBL] [Abstract][Full Text] [Related]
4. Thymus-dependent modulation of Ly49 inhibitory receptor expression on NK1.1+gamma/delta T cells.
Hara T; Nishimura H; Hasegawa Y; Yoshikai Y
Immunology; 2001 Jan; 102(1):24-30. PubMed ID: 11168633
[TBL] [Abstract][Full Text] [Related]
5. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
6. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells.
Fahlén L; Lendahl U; Sentman CL
J Immunol; 2001 Jun; 166(11):6585-92. PubMed ID: 11359811
[TBL] [Abstract][Full Text] [Related]
7. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
Sköld M; Faizunnessa NN; Wang CR; Cardell S
J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
[TBL] [Abstract][Full Text] [Related]
9. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
10. Clonal analysis of NK cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression.
Williams NS; Kubota A; Bennett M; Kumar V; Takei F
Eur J Immunol; 2000 Jul; 30(7):2074-82. PubMed ID: 10940897
[TBL] [Abstract][Full Text] [Related]
11. Control of NKT cell differentiation by tissue-specific microenvironments.
Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
[TBL] [Abstract][Full Text] [Related]
12. Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes.
Van Beneden K; De Creus A; Stevenaert F; Debacker V; Plum J; Leclercq G
J Immunol; 2002 Apr; 168(7):3295-302. PubMed ID: 11907085
[TBL] [Abstract][Full Text] [Related]
13. Two structurally related rat Ly49 receptors with opposing functions (Ly49 stimulatory receptor 5 and Ly49 inhibitory receptor 5) recognize nonclassical MHC class Ib-encoded target ligands.
Naper C; Dai KZ; Kveberg L; Rolstad B; Niemi EC; Vaage JT; Ryan JC
J Immunol; 2005 Mar; 174(5):2702-11. PubMed ID: 15728478
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice.
Salcedo M; Diehl AD; Olsson-Alheim MY; Sundbäck J; Van Kaer L; Kärre K; Ljunggren HG
J Immunol; 1997 Apr; 158(7):3174-80. PubMed ID: 9120271
[TBL] [Abstract][Full Text] [Related]
15. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model.
Hanke T; Takizawa H; Raulet DH
Eur J Immunol; 2001 Nov; 31(11):3370-9. PubMed ID: 11745355
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family.
Dimasi N; Sawicki MW; Reineck LA; Li Y; Natarajan K; Margulies DH; Mariuzza RA
J Mol Biol; 2002 Jul; 320(3):573-85. PubMed ID: 12096910
[TBL] [Abstract][Full Text] [Related]
17. An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire.
Held W; Kunz B
Eur J Immunol; 1998 Aug; 28(8):2407-16. PubMed ID: 9710218
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire.
Held W; Dorfman JR; Wu MF; Raulet DH
Eur J Immunol; 1996 Oct; 26(10):2286-92. PubMed ID: 8898935
[TBL] [Abstract][Full Text] [Related]
19. CD1d-restricted NKT cells: an interstrain comparison.
Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
[TBL] [Abstract][Full Text] [Related]
20. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors.
Lowin-Kropf B; Kunz B; Schneider P; Held W
Eur J Immunol; 2002 Mar; 32(3):773-82. PubMed ID: 11870621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
